EdgarLookup

Ferguson Enterprises Inc. /DE/ — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Ferguson Enterprises Inc. /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
6%
Profit Margin
Net income ÷ revenue
10.5%
Return on Assets
Net income ÷ assets
2.04x
Debt-to-Equity
Total liabilities ÷ equity
+3.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $30.76B Sep 26, 2025
FY2025 Jul 31, 2024 $29.64B Sep 26, 2025
FY2025 Jul 31, 2023 $29.73B Sep 26, 2025
FY2024 Jul 31, 2022 $28.57B Sep 25, 2024

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $9.44B Sep 26, 2025
FY2025 Jul 31, 2024 $9.05B Sep 26, 2025
FY2025 Jul 31, 2023 $9.03B Sep 26, 2025
FY2024 Jul 31, 2022 $8.76B Sep 25, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $1.86B Sep 26, 2025
FY2025 Jul 31, 2024 $1.74B Sep 26, 2025
FY2025 Jul 31, 2023 $1.89B Sep 26, 2025
FY2024 Jul 31, 2022 $2.12B Sep 25, 2024

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $2.61B Sep 26, 2025
FY2025 Jul 31, 2024 $2.65B Sep 26, 2025
FY2025 Jul 31, 2023 $2.66B Sep 26, 2025
FY2024 Jul 31, 2022 $2.82B Sep 25, 2024

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $6.38B Sep 26, 2025
FY2025 Jul 31, 2024 $6.04B Sep 26, 2025
FY2025 Jul 31, 2023 $5.92B Sep 26, 2025
FY2024 Jul 31, 2022 $5.64B Sep 25, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $1.91B Sep 26, 2025
FY2025 Jul 31, 2024 $1.87B Sep 26, 2025
FY2025 Jul 31, 2023 $2.72B Sep 26, 2025
FY2024 Jul 31, 2022 $1.15B Sep 25, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $17.73B Sep 26, 2025
FY2025 Jul 31, 2024 $16.57B Sep 26, 2025
FY2024 Jul 31, 2023 $15.99B Sep 25, 2024

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $11.90B Sep 26, 2025
FY2025 Jul 31, 2024 $10.96B Sep 26, 2025
FY2024 Jul 31, 2023 $10.96B Sep 25, 2024

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $5.83B Sep 26, 2025
FY2025 Jul 31, 2024 $5.62B Sep 26, 2025
FY2025 Jul 31, 2023 $5.04B Sep 26, 2025
FY2024 Jul 31, 2022 $4.67B Sep 25, 2024
FY2024 Jul 31, 2021 $5.00B Sep 25, 2024

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $2.46B Sep 26, 2025
FY2025 Jul 31, 2024 $2.36B Sep 26, 2025
FY2025 Jul 31, 2023 $2.24B Sep 26, 2025
FY2024 Jul 31, 2022 $2.05B Sep 25, 2024

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $6.78B Sep 26, 2025
FY2025 Jul 31, 2024 $9.59B Sep 26, 2025
FY2024 Jul 31, 2023 $8.56B Sep 25, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $674.00M Sep 26, 2025
FY2025 Jul 31, 2024 $571.00M Sep 26, 2025
FY2025 Jul 31, 2023 $601.00M Sep 26, 2025
FY2024 Jul 31, 2022 $771.00M Sep 25, 2024

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 $4.18B Sep 26, 2025
FY2024 Jul 31, 2024 $3.95B Sep 25, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 9 Sep 26, 2025
FY2025 Jul 31, 2024 8 Sep 26, 2025
FY2025 Jul 31, 2023 9 Sep 26, 2025
FY2024 Jul 31, 2022 9 Sep 25, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jul 31, 2025 9 Sep 26, 2025
FY2025 Jul 31, 2024 8 Sep 26, 2025
FY2025 Jul 31, 2023 9 Sep 26, 2025
FY2024 Jul 31, 2022 9 Sep 25, 2024